Clinical changes of leptin/ghrelin and PAI-1 levels in adolescent girls with abnormal uterine bleeding-ovulatory dysfunction

Gynecol Endocrinol. 2022 Apr;38(4):345-349. doi: 10.1080/09513590.2022.2045938. Epub 2022 Mar 3.

Abstract

Objective: To observe and compare the expression of energy regulators (leptin/ghrelin) and PAI-1 in girls with abnormal uterine bleeding-ovulatory dysfunction (AUB-O) and healthy adolescent girls.

Methods: A total of 80 adolescent girls were studied including 60 with AUB-O and 20 healthy girls. All the general characteristics of subjects including height, weight, age, and age at menarche were collected after consent. The concentration of plasma leptin, ghrelin, PAI-1, and sex hormones was examined using enzyme-linked immunosorbent assay (ELISA) and DXI800 Access immunoassay system respectively.

Results: Two groups were comparable in the age at menarche, visiting age, postmenarchal years, and BMI SDS (p > .05). Levels of leptin (11.12 ± 4.96 ng/ml vs. 18.59 ± 13.22 ng/ml, p < .001) and PAI-1 (116.40 ± 36.63 ng/ml vs. 173.19 ± 52.44 ng/ml, p < .001) in girls with AUB-O were significantly lower than that in healthy girls, and the levels of ghrelin were significantly higher than that in healthy girls (1.52 ± 4.20 ng/ml vs. 0.43 ± 0.64 ng/ml, p = .01). At the same time, we also found that girls with AUB-O showed negative correlation between the level of leptin, ghrelin, and estradiol.

Conclusions: Energy metabolism and coagulation might play a role in the development of AUB-O in adolescent girls.

Keywords: Abnormal uterine bleeding-ovulatory dysfunction; PAI-1; ghrelin; leptin; metrorrhagia.

MeSH terms

  • Adolescent
  • Body Height
  • Female
  • Ghrelin
  • Humans
  • Leptin / blood*
  • Plasminogen Activator Inhibitor 1 / blood*
  • Uterine Hemorrhage

Substances

  • Ghrelin
  • LEP protein, human
  • Leptin
  • Plasminogen Activator Inhibitor 1
  • SERPINE1 protein, human